Compugen Ltd (CGEN.OQ)
CGEN.OQ on NASDAQ Stock Exchange Global Market
3.63USD
22 Mar 2019
3.63USD
22 Mar 2019
Change (% chg)
$-0.06 (-1.63%)
$-0.06 (-1.63%)
Prev Close
$3.69
$3.69
Open
$3.66
$3.66
Day's High
$3.74
$3.74
Day's Low
$3.62
$3.62
Volume
32,814
32,814
Avg. Vol
37,094
37,094
52-wk High
$5.00
$5.00
52-wk Low
$2.00
$2.00
About
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage... (more)
Overall
| Beta: | 0.65 |
| Market Cap(Mil.): | $175.64 |
| Shares Outstanding(Mil.): | 51.13 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CGEN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.32 | 32.54 |
| EPS (TTM): | -0.67 | -- | -- |
| ROI: | -52.36 | 8.89 | 13.82 |
| ROE: | -54.94 | 10.02 | 15.24 |
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV, Oct 11 Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumours.
Estimates